Commitment to their community drove many pharmacists to go above and beyond their usual standard of service to ensure patients had access to crucial medicines as fear of infection with COVID-19 kept many older patients from leaving home. In other cases, the local pharmacist became the only healthcare professional patients could see in person as clinics and hospitals instituted pandemic precautions. 

In Pennsylvania, Richard Ost, owner of Philadelphia Pharmacy in Kensington, reported that his pharmacy now delivers 90% of its prescriptions, as many of his patients remain afraid to leave their homes because of COVID-19. That comes to about 150 prescriptions every day.

“A lot of our customers are elderly and have several severe conditions: diabetes, high blood pressure, heart problems. They need their medication that day,” Dr. Ost told PHL17 Morning News.  

He is not alone in seeing growth in demand for delivery. 

“We doubled our delivery service and started curbside service to keep our patients and employees safe,” said Brian Caswell, National Community Pharmacists Association (NCPA) president and owner of Wolkar Drug in Baxter Springs, Kansas. “Most local pharmacists think those are services that consumers will value after the national emergency fades.”

A survey published by the NCPA June 1 found that 82% of community pharmacists expect to continue expanded home delivery and curbside service.

Community pharmacists also plan to continue other services that they began to offer or enhanced in the last few months.

While three-quarters of the pharmacists surveyed had not provided point-of-care testing prior to the pandemic, 61% anticipated that they and other local pharmacies would test for a variety of illnesses going forward. The U.S. Department of Health and Human Services authorized testing for COVID-19 at pharmacies in April, and about 70% of states had changed their regulations to permit testing at pharmacies by early June.

Testing represents just one aspect of the expanded scope of practice pharmacists have seen over the last few months, and many anticipate that they will perform more healthcare services on a regular basis. 

Additional services include offering vaccinations, which had been authorized in many states before the pandemic. In 2019, 73% of community pharmacies offered immunizations, but only 25% provided more than the influenza vaccine. When a vaccine for the SARS-CoV-2 virus is developed, many pharmacists expect to add it to their services. In late May, Minnesota passed the first law in the nation allowing pharmacists to administer the SARS-CoV-2/COVID-19 vaccine when one is approved.

More than half of respondents to the NCPA survey expected more pharmacies to provide immunizations. This would be a great time to start offering an expanded range of vaccines, as the CDC has reported a sharp drop in immunizations among children during the pandemic. 

That has caused the CDC to express concern about a resurgence in preventable diseases. “The observed declines in vaccination coverage might leave young children and communities vulnerable to vaccine-preventable diseases such as measles,” CDC researchers said. “If measles vaccination coverage of 90%-95% . . . is not achieved, measles outbreaks can occur.” 

With most schools planning to reopen in the fall, there will be a crush of demand to bring immunizations up to date. According to the American Pharmacists Association, 27 states allowed pharmacists to immunize patients of any age and 46 permitted them to provide any vaccine as of 2019. States have varying requirements for protocols, prescriptions, and other restrictions for pediatric vaccinations, but pharmacists have found immunizations for children and adults a valuable booster to profits.

« Click here to return to COVID-19 Update.